Articles Tagged With:
-
Travel Medicine Advisor April 2010 Issue in PDF
-
Trichinellosis in the United States: A Shift from Swine to Bears
Dr. Blackburn is Clinical Assistant Professor in the Division of Infectious Diseases and Geographic Medicine at Stanford University School of Medicine. Dr. Barry is Senior Associate Dean of Global Health at Stanford University School of Medicine. -
Beware of Bat Caves! Marburg Hemorrhagic Fever in a Traveler
A 44-year-old Colorado woman developed severe headaches, chills, nausea, and diarrhea in January 2008, three days after returning from a two-week safari trip to Uganda. Self-medication for traveler's diarrhea with ciprofloxacin did not improve her symptoms. -
Chagas Symposium: Blood Bank Screening and Diagnostic Options
Caryn Bern from the Centers for Disease Control and Prevention (CDC), Atlanta, discussed the evaluation of patients with suspected Chagas disease and decisions regarding testing. -
Pharmacology Watch: Thiazolidinediones and Risk of Heart Failure
n this issue: FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions. -
Clinical Briefs in Primary Care supplement
-
CDC Updates from American Society of Tropical Medicine and Hygiene — 2009 Annual Meeting, Washington, DC
From 1985 to 2008, the malaria surveillance program in the United States recorded an average of 1400 malaria cases and 5 deaths per year. In 2008, 1298 cases were reported, including one congenital case. -
Infectious Disease Alert April 2010 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Updates by Carol Kemper, MD, FACP
Yellow fever vaccine (YFV) is a live, attenuated viral vaccine that is manufactured using a variety of strains of YF virus. Milder side effects of YFV occur in 2%-10% of people (headache, muscle aches, and fever) within 3 to 9 days of vaccination.